ISSN: 0941-4355
Journal Home
Journal Guideline
Supportive Care in Cancer Q2 Unclaimed
Supportive Care in Cancer is a journal indexed in SJR in Oncology with an H index of 120. It has a price of 3290 €. It has an SJR impact factor of 0.949 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0.949.
Supportive Care in Cancer focuses its scope in these topics and keywords: cancer, patients, care, palliative, breast, early, standard, treatment, trial, status, ...
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy: Open Choice
Type of publications:
Publication frecuency: -


3290 €
Inmediate OANPD
Embargoed OA0 €
Non OAMetrics
0.949
SJR Impact factor120
H Index850
Total Docs (Last Year)1654
Total Docs (3 years)30120
Total Refs5997
Total Cites (3 years)1526
Citable Docs (3 years)3.45
Cites/Doc (2 years)35.44
Ref/DocOther journals with similar parameters
BMC Cancer Q2
International Journal of Oncology Q2
Current Opinion in Oncology Q2
Cancer Cytopathology Q2
Cancer Cell International Q2
Compare this journals
Aims and Scope
Best articles by citations
Associations among awareness of prognosis, hopefulness, and coping in patients with advanced cancer participating in phase I clinical trials
View moreThe importance of clinical practice guidelines (CPGs) for the quality and development of supportive care in Central and Eastern European (CEE) countries
View moreDaily activities: exploring their spectrum and prognostic impact in older, chemotherapy-treated lung cancer patients
View moreQuality of the supportive and palliative oncology literature: a focused analysis on randomized controlled trials
View moreThe years after: a concept of the psychological integration of childhood cancer
View moreCamping programs for children with cancer and their families
View moreThe relationship between patient characteristics and carer psychological status in home palliative cancer care
View moreEfficacy of traditional Chinese Medicine combined with chemotherapy in patients with non-small cell lung cancer (NSCLC): a meta-analysis of randomized clinical trials
View morePalliative surgery of acrometastases from lung cancer: a case report
View moreNo public health without public death?ethical considerations
View moreEffectiveness of a teaching programme in pain and symptom management for junior house officers
View moreConstipation?modern laxative therapy
View moreSymptom management: the utility of regional cooling for hand-foot syndrome induced by pegylated liposomal doxorubicin in ovarian cancer
View moreGranisetron in the control of nausea and vomiting associated with bone marrow transplantation: a review of its efficacy and tolerability
View moreImpact of radiation-induced nausea and vomiting on quality of life
View moreImpact of initiating antiemetic prophylaxis with palonosetron versus ondansetron on risk of uncontrolled chemotherapy-induced nausea and vomiting in patients with lung cancer receiving multi-day chemotherapy
View moreAn information system to support the care for head and neck cancer patients
View moreVolume of hydration in terminal cancer patients
View moreEconomic evaluation of antiaromatase agents in the second-line treatment of metastatic breast cancer
View moreDefining optimal control of chemotherapy-induced nausea and vomiting - based on patients' experience
View moreA bedside food cart as an alternate food service for acute and palliative oncological patients
View moreThe success of data collection in the palliative setting?telephone or clinic follow-up?
View moreCare of breast cancer in the elderly woman?what does comprehensive geriatric assessment (CGA) help?
View moreVoriconazole for invasive aspergillosis in oncohematological patients: a single-center pediatric experience
View more
Comments